Erratum to: Targeting the wnt pathway in zebrafish as a screening method to identify novel therapeutic compounds (Experimental Biology and Medicine, (2015), 239, (169-176) 20130432, (10.1177/1535370213514322));Targeting the Wnt pathway in zebrafish as a screening method to identify novel therapeutic compounds

Experimental Biology and Medicine

Volumn 239, Issue 2, 2014, Pages 169-176

  Robertson, Joshua K ^a   Danzmann, Kestral ^a   Charles, Sherise ^a   Blake, Katherine ^a   Olivares, Annia ^a   Bamikole, Solape ^a   Olson, Meghan ^a   Raay, Terence J Van ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Cancer; eyeless; LiCl; small molecules; Wnt signaling; zebrafish

Indexed keywords

AXIN; BETA CATENIN; CASEIN KINASE I; GLYCOGEN SYNTHASE KINASE 3 INHIBITOR; LITHIUM CHLORIDE; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; TANKYRASE; TANKYRASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DRUG SCREENING; EMBRYO; EMBRYONIC STEM CELL; EXPERIMENTAL HYPERACTIVITY; EYE MALFORMATION; EYELESS; GASTRULATION; NONHUMAN; PHENOTYPE; SOMATIC MUTATION; WNT SIGNALING PATHWAY; ZEBRA FISH;

CANCER; EYELESS; LICL; SMALL MOLECULES; WNT SIGNALING; ZEBRAFISH;

ANIMALS; COLORECTAL NEOPLASMS; DRUG EVALUATION, PRECLINICAL; EMBRYO, NONMAMMALIAN; EMBRYONIC DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOGEN SYNTHASE KINASE 3; HETEROCYCLIC COMPOUNDS, 3-RING; LITHIUM CHLORIDE; PHENOTYPE; WNT SIGNALING PATHWAY; ZEBRAFISH;

EID: 84893910790     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213514322     Document Type: Erratum

References (69)

1. Network TCGA.Comprehensive molecular characterization of human colon and rectal cancer.Nature. 2012;487:330-7.
2. Korinek V,Barker N,Morin PJ,van Wichen D,de Weger R,Kinzler KW,Vogelstein B,Clevers H.Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.Science. 1997;275:1784-7.
3. Kinzler KW,Vogelstein B.Lessons from hereditary colorectal cancer.Cell. 1996;87:159-70.
4. Kemper K,Grandela C,Medema JP.Molecular identification and targeting of colorectal cancer stem cells.Oncotarget. 2010;1:387-95.
5. Vermeulen L,de Sousa e Melo F,Richel DJ,Medema JP.The developing cancer stem-cell model: clinical challenges and opportunities.Lancet Oncol. 2012;13:e83-9.
6. Sampieri K,Fodde R.Cancer stem cells and metastasis.Semin Cancer Biol. 2012;22:187-93.
7. Visvader JE,Lindeman GJ.Cancer stem cells: current status and evolving complexities.Cell Stem Cell. 2012;10:717-28.
8. Medema JP,Vermeulen L.Microenvironmental regulation of stem cells in intestinal homeostasis and cancer.Nature. 2011;474:318-26.
9. de Sousa EM,Vermeulen L,Richel D,Medema JP.Targeting Wnt signaling in colon cancer stem cells.Clin Cancer Res. 2011;17:647-53.
10. Curtin JC,Lorenzi MV.Drug discovery approaches to target Wnt signaling in cancer stem cells.Oncotarget. 2012;1:563-77.
11. Vermeulen L,De Sousa EMF,van der Heijden M,Cameron K,de Jong JH,Borovski T,Tuynman JB,Todaro M,Merz C,Rodermond H,Sprick MR,Kemper K,Richel DJ,Stassi G,Medema JP.Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.Nat Cell Biol. 2010;12:468-76.
12. Kypta RM,Waxman J.Wnt/beta-catenin signalling in prostate cancer.Nat Rev Urol. 2012;9:418-28.
13. Hallett RM,Kondratyev MK,Giacomelli AO,Nixon AM,Girgis-Gabardo A,Ilieva D,Hassell JA.Small molecule antagonists of the Wnt/beta-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.PLoS One. 2012;7:e33976-e33976.
14. Vangipuram SD,Buck SA,Lyman WD.Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.Tumour Biol. 2012;33:2173-83.
15. Herencia C,Martinez-Moreno JM,Herrera C,Corrales F,Santiago-Mora R,Espejo I,Barco M,Almaden Y,de la Mata M,Rodriguez-Ariza A,Munoz-Castaneda JR.Nuclear translocation of beta-catenin during mesenchymal stem cells differentiation into hepatocytes is associated with a tumoral phenotype.PLoS One. 2012;7:e34656-e34656.
16. Schepers A,Clevers H.Wnt signaling, stem cells, and cancer of the gastrointestinal tract.Cold Spring Harb Perspect Biol. 2012;4:a007989-a007989.
17. Polakis P.Drugging Wnt signalling in cancer.EMBO J. 2012;31:2737-46.
18. Holstein TW.The evolution of the wnt pathway.Cold Spring Harb Perspect Biol. 2012;4:a007922-a007922.
19. Ramel MC,Lekven AC.Repression of the vertebrate organizer by Wnt8 is mediated by Vent and Vox.Development. 2004;131:3991-4000.
20. Erter CE,Wilm TP,Basler N,Wright CV,Solnica-Krezel L.Wnt8 is required in lateral mesendodermal precursors for neural posteriorization in vivo.Development. 2001;128:3571-83.
21. Fekany-Lee K,Gonzalez E,Miller-Bertoglio V,Solnica-Krezel L.The homeobox gene bozozok promotes anterior neuroectoderm formation in zebrafish through negative regulation of BMP2/4 and Wnt pathways.Development. 2000;127:2333-45.
22. Lekven AC,Thorpe CJ,Waxman JS,Moon RT.Zebrafish wnt8 encodes two wnt8 proteins on a bicistronic transcript and is required for mesoderm and neurectoderm patterning.Dev Cell. 2001;1:103-14.
23. Hamm EE,Voth DE,Ballard JD.Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication.Proc Natl Acad Sci U S A. 2006;103:14176-81.
24. Sukardi H,Chng HT,Chan EC,Gong Z,Lam SH.Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models.Expert Opin Drug Metab Toxicol. 2011;7:579-89.
25. Faro A,Boj SF,Clevers H.Fishing for intestinal cancer models: unraveling gastrointestinal homeostasis and tumorigenesis in zebrafish.Zebrafish. 2009;6:361-76.
26. Kim MS,Yoon SK,Bollig F,Kitagaki J,Hur W,Whye NJ,Wu YP,Rivera MN,Park JY,Kim HS,Malik K,Bell DW,Englert C,Perantoni AO,Lee SB.A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.J Biol Chem. 2010;285:14585-93.
27. Tobin JL,Di Franco M,Eichers E,May-Simera H,Garcia M,Yan J,Quinlan R,Justice MJ,Hennekam RC,Briscoe J,Tada M,Mayor R,Burns AJ,Lupski JR,Hammond P,Beales PL.Inhibition of neural crest migration underlies craniofacial dysmorphology and Hirschsprung's disease in Bardet-Biedl syndrome.Proc Natl Acad Sci U S A. 2008;105:6714-9.
28. Cselenyi CS,Jernigan KK,Tahinci E,Thorne CA,Lee LA,Lee E.LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin.Proc Natl Acad Sci U S A. 2008;105:8032-7.
29. Niehrs C,Shen J.Regulation of Lrp6 phosphorylation.Cell Mol Life Sci. 2010;67:2551-62.
30. MacDonald BT,Tamai K,He X.Wnt/beta-catenin signaling: components, mechanisms, and diseases.Dev Cell. 2009;17:9-26.
31. Van Raay TJ,Vetter ML.Wnt/frizzled signaling during vertebrate retinal development.Dev Neurosci. 2004;26:352-8.
32. Reya T,Clevers H.Wnt signalling in stem cells and cancer.Nature. 2005;434:843-50.
33. Klaus A,Birchmeier W.Wnt signalling and its impact on development and cancer.Nat Rev Cancer. 2008;8:387-98.
34. Freese JL,Pino D,Pleasure SJ.Wnt signaling in development and disease.Neurobiol Dis. 2010;38:148-53.
35. Jho EH,Zhang T,Domon C,Joo CK,Freund JN,Costantini F.Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway.Mol Cell Biol. 2002;22:1172-83.
36. Leung JY,Kolligs FT,Wu R,Zhai Y,Kuick R,Hanash S,Cho KR,Fearon ER.Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.J Biol Chem. 2002;277:21657-65.
37. Wharton KA,Zimmermann G,Rousset R,Scott MP.Vertebrate proteins related to Drosophila Naked Cuticle bind Dishevelled and antagonize Wnt signaling.Dev Biol. 2001;234:93-106.
38. Yan D,Wallingford JB,Sun TQ,Nelson AM,Sakanaka C,Reinhard C,Harland RM,Fantl WJ,Williams LT.Cell autonomous regulation of multiple Dishevelled-dependent pathways by mammalian Nkd.Proc Natl Acad Sci U S A. 2001;98:3802-7.
39. Yan D,Wiesmann M,Rohan M,Chan V,Jefferson AB,Guo L,Sakamoto D,Caothien RH,Fuller JH,Reinhard C,Garcia PD,Randazzo FM,Escobedo J,Fantl WJ,Williams LT.Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.Proc Natl Acad Sci U S A. 2001;98:14973-8.
40. Van Raay TJ,Coffey RJ,Solnica-Krezel L.Zebrafish Naked1 and Naked2 antagonize both canonical and non-canonical Wnt signaling.Dev Biol. 2007;309:151-68.
41. Chan TM,Longabaugh W,Bolouri H,Chen HL,Tseng WF,Chao CH,Jang TH,Lin YI,Hung SC,Wang HD,Yuh CH.Developmental gene regulatory networks in the zebrafish embryo.Biochim Biophys Acta. 2009;1789:279-98.
42. Hikasa H,Sokol SY.Wnt signaling in vertebrate axis specification.Cold Spring Harb Perspect Biol. 2013;5:a007955-a007955.
43. Bellipanni G,Varga M,Maegawa S,Imai Y,Kelly C,Myers AP,Chu F,Talbot WS,Weinberg ES.Essential and opposing roles of zebrafish beta-catenins in the formation of dorsal axial structures and neurectoderm.Development. 2006;133:1299-1309.
44. Heisenberg CP,Houart C,Take-Uchi M,Rauch GJ,Young N,Coutinho P,Masai I,Caneparo L,Concha ML,Geisler R,Dale TC,Wilson SW,Stemple DL.A mutation in the Gsk3-binding domain of zebrafish Masterblind/Axin1 leads to a fate transformation of telencephalon and eyes to diencephalon.Genes Dev. 2001;15:1427-34.
45. van de Water S,van de Wetering M,Joore J,Esseling J,Bink R,Clevers H,Zivkovic D.Ectopic Wnt signal determines the eyeless phenotype of zebrafish masterblind mutant.Development. 2001;128:3877-88.
46. Kim CH,Oda T,Itoh M,Jiang D,Artinger KB,Chandrasekharappa SC,Driever W,Chitnis AB.Repressor activity of Headless/Tcf3 is essential for vertebrate head formation.Nature. 2000;407:913-6.
47. Cavodeassi F,Carreira-Barbosa F,Young RM,Concha ML,Allende ML,Houart C,Tada M,Wilson SW.Early stages of zebrafish eye formation require the coordinated activity of Wnt11, Fz5, and the Wnt/beta-catenin pathway.Neuron. 2005;47:43-56.
48. Momoi A,Yoda H,Steinbeisser H,Fagotto F,Kondoh H,Kudo A,Driever W,Furutani-Seiki M.Analysis of Wnt8 for neural posteriorizing factor by identifying Frizzled 8c and Frizzled 9 as functional receptors for Wnt8.Mech Dev. 2003;120:477-89.
49. de Sousa EM,Vermeulen L,Richel D,Medema JP.Targeting Wnt signaling in colon cancer stem cells.Clin Cancer Res. 2010;17:647-53.
50. Takebe N,Harris PJ,Warren RQ,Ivy SP.Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.Nat Rev Clin Oncol. 2010;8:97-106.
51. Watanabe K,Dai X.Winning WNT: race to Wnt signaling inhibitors.Proc Natl Acad Sci U S A. 2011;108:5929-30.
52. Gonsalves FC,Klein K,Carson BB,Katz S,Ekas LA,Evans S,Nagourney R,Cardozo T,Brown AM,DasGupta R.An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway.Proc Natl Acad Sci U S A. 2011;108:5954-63.
53. Ewan K,Pajak B,Stubbs M,Todd H,Barbeau O,Quevedo C,Botfield H,Young R,Ruddle R,Samuel L,Battersby A,Raynaud F,Allen N,Wilson S,Latinkic B,Workman P,McDonald E,Blagg J,Aherne W,Dale T.A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription.Cancer Res. 2010;70:5963-73.
54. Lepourcelet M,Chen YN,France DS,Wang H,Crews P,Petersen F,Bruseo C,Wood AW,Shivdasani RA.Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex.Cancer Cell. 2004;5:91-102.
55. Huang SM,Mishina YM,Liu S,Cheung A,Stegmeier F,Michaud GA,Charlat O,Wiellette E,Zhang Y,Wiessner S,Hild M,Shi X,Wilson CJ,Mickanin C,Myer V,Fazal A,Tomlinson R,Serluca F,Shao W,Cheng H,Shultz M,Rau C,Schirle M,Schlegl J,Ghidelli S,Fawell S,Lu C,Curtis D,Kirschner MW,Lengauer C,Finan PM,Tallarico JA,Bouwmeester T,Porter JA,Bauer A,Cong F.Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.Nature. 2009;461:614-20.
56. Chen B,Dodge ME,Tang W,Lu J,Ma Z,Fan CW,Wei S,Hao W,Kilgore J,Williams NS,Roth MG,Amatruda JF,Chen C,Lum L.Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer.Nat Chem Biol. 2009;5:100-07.
57. Waaler J,Machon O,von Kries JP,Wilson SR,Lundenes E,Wedlich D,Gradl D,Paulsen JE,Machonova O,Dembinski JL,Dinh H,Krauss S.Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth.Cancer Res. 2011;71:197-205.
58. Wang W,Liu H,Wang S,Hao X,Li L.A diterpenoid derivative 15-oxospiramilactone inhibits Wnt/beta-catenin signaling and colon cancer cell tumorigenesis.Cell Res. 2011;21:730-40.
59. Chen W,Chen M,Barak LS.Development of small molecules targeting the Wnt pathway for the treatment of colon cancer: a high-throughput screening approach.Am J Physiol Gastrointest Liver Physiol. 2010;299:G293-300.
60. Thorne CA,Hanson AJ,Schneider J,Tahinci E,Orton D,Cselenyi CS,Jernigan KK,Meyers KC,Hang BI,Waterson AG,Kim K,Melancon B,Ghidu VP,Sulikowski GA,LaFleur B,Salic A,Lee LA,Miller DM,Lee E.Small-molecule inhibition of Wnt signaling through activation of casein kinase 1alpha.Nat Chem Biol. 2010;6:829-36.
61. Hao J,Ao A,Zhou L,Murphy CK,Frist AY,Keel JJ,Thorne CA,Kim K,Lee E,Hong CC.Selective small molecule targeting beta-catenin function discovered by in vivo chemical genetic screen.Cell Rep. 2013;4:898-904.
62. Zhong H,Lin S.Chemical screening with zebrafish embryos.Meth Mol Biol. 2011;716:193-205.
63. Grinshtein N,Datti A,Fujitani M,Uehling D,Prakesch M,Isaac M,Irwin MS,Wrana JL,Al-Awar R,Kaplan DR.Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.Cancer Res. 2011;71:1385-95.
64. Emami KH,Nguyen C,Ma H,Kim DH,Jeong KW,Eguchi M,Moon RT,Teo JL,Kim HY,Moon SH,Ha JR,Kahn M.A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].Proc Natl Acad Sci U S A. 2004;101:12682-7.
65. Stachel SE,Grunwald DJ,Myers PZ.Lithium perturbation and goosecoid expression identify a dorsal specification pathway in the pregastrula zebrafish.Development. 1993;117:1261-74.
66. Brand M,Heisenberg CP,Warga RM,Pelegri F,Karlstrom RO,Beuchle D,Picker A,Jiang YJ,Furutani-Seiki M,van Eeden FJ,Granato M,Haffter P,Hammerschmidt M,Kane DA,Kelsh RN,Mullins MC,Odenthal J,Nusslein-Volhard C.Mutations affecting development of the midline and general body shape during zebrafish embryogenesis.Development. 1996;123:129-42.
67. Gritsman K,Zhang J,Cheng S,Heckscher E,Talbot WS,Schier AF.The EGF-CFC protein one-eyed pinhead is essential for nodal signaling.Cell. 1999;97:121-32.
68. Liu X,Xiong C,Jia S,Zhang Y,Chen YG,Wang Q,Meng A.Araf kinase antagonizes Nodal-Smad2 activity in mesendoderm development by directly phosphorylating the Smad2 linker region.Nat Commun. 2013;4:1728-1728.
69. Bamford RN,Roessler E,Burdine RD,Saplakoglu U,dela Cruz J,Splitt M,Goodship JA,Towbin J,Bowers P,Ferrero GB,Marino B,Schier AF,Shen MM,Muenke M,Casey B.Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects.Nat Genet. 2000;26:365-9.